Organigram Global (OGI) Gains from Investment Securities (2018 - 2026)

Organigram Global (OGI) reported Gains from Investment Securities of -$3.5 million for Q1 2026, down 29.08% year-over-year from -$4.9 million in Q1 2025, and down 170.39% quarter-over-quarter from -$1.3 million in Q4 2025.

Organigram Global (OGI) Gains from Investment Securities (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has 6 years of Gains from Investment Securities data on file, last reported at -$3.5 million in Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at -$3.5 million, down 29.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.5 million (down 121.59% YoY), and the FY2025 annual result was $6539.7, up 101.41% from the prior year.
  • Gains from Investment Securities fell to -$3.5 million in Q1 2026 per OGI's latest filing, from -$1.3 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at -$1.3 million in Q4 2025 and troughed at -$3.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Organigram Global 714.36 Mn 656.41 Mn 11.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.51 Mn
Mar 31, 2026 -3.51 Mn
Dec 31, 2025 -1.30 Mn
Dec 31, 2025 -1.30 Mn
Mar 31, 2025 -2.72 Mn
Mar 31, 2025 -2.72 Mn
May 31, 2021 -24,000.00
May 31, 2021 -24,000.00
Feb 28, 2021 37.66 Mn
Feb 28, 2021 37.66 Mn
Nov 30, 2020 36,000.00
Nov 30, 2020 36,000.00
Aug 31, 2020 -980,075.55
Aug 31, 2020 -980,075.55
May 31, 2020 33,609.58
May 31, 2020 33,609.58
Feb 29, 2020 91,000.00
Feb 29, 2020 91,000.00
Nov 30, 2019 401,000.00
Nov 30, 2019 401,000.00